Synopsis
Ipca Laboratories Ltd hit a fresh record high in October 2024, breaking a 2-week consolidation. Experts suggest the rally may continue, with short-term traders targeting Rs 1,650-1,680 in 1-2 months. The stock has been on an upward trend, trading above key moving averages. Traders are encouraged to buy, with a stop loss below Rs 1,450.
Ipca Laboratories Ltd, part of the pharma space, broke a 2-week consolidation to hit a fresh record high in October 2024 and chart pattern suggests that the rally may not be over yet.Short-term traders can look to buy for a target of Rs 1,650-1,680 in the next 1-2 months, suggest experts.The pharma stock has rallied more than 30% in the last 3 months. The momentum helped the stock to breakout from the 2-week consolidation seen on the daily
- FONT SIZE
AbcSmall
AbcMedium
AbcLarge
Uh-oh! This is an exclusive story available for selected readers only.
Worry not. Youβre just a step away.
Why ?
Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors
-
Stock analysis. Market Research. Industry Trends on 4000+ Stocks
-
Clean experience with
Minimal Ads -
Comment & Engage with ET Prime community -
Exclusive invites to Virtual Events with Industry Leaders -
A trusted team of Journalists & Analysts who can best filter signal from noise -
βGet 1 Year Complimentary Subscription of TOI+ worth Rs.799/-β
Source link
